Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes

Inclusion Criteria: * Signed informed consent obtained before any trial-related activities. (Trial-related activities are any procedure that would not have been performed during normal management of the subject) * The subject must have completed the ANA/DCD/065 trial Exclusion Criteria: * Impaired hepatic function * Impaired renal function * Total daily insulin requirements of more than 1.4 U/kg * Cardiac problems * Uncontrolled hypertension * Known or suspected allergy to trial product or related products * Current hypoglycaemic unawareness as judged by the investigator * Known or suspect abuse of alcohol or narcotics * Women breastfeeding or having the intention of becoming pregnant, or if judged not to be using adequate contraceptive measures (adequate measures are intrauterine device (IUD), oral contraception and barrier methods) * Any condition that the Investigator and/or Sponsor feels would interfere with trial participation or evaluation of results